Sarcomatrix Therapeutics Corp.
PrivateLast Round
Seed
Aug 22, 2025
Est. Valuation
$14.25M
Total Funding Raised
$1.96M
Company Overview
Sarcomatrix Therapeutics Corp. is a biotechnology company that develops novel small-molecule therapeutics and protein replacement therapies for muscle-wasting diseases such as muscular dystrophy, sarcopenia, and cachexia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sarcomatrix Therapeutics Corp. Comparables
Compare Sarcomatrix Therapeutics Corp. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Strykagen Corp | 89% | |
| Epirium Bio | 71% | |
| Biophytis SA | 71% | |
Sarcomatrix Therapeutics Corp. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 22, 2025 | ||||
| Crowdfunding | Jul 8, 2024 | ||||
| Grant | Sep 20, 2023 |
Key People
Founding team and executive leadership
Sarcomatrix Therapeutics Corp. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
Sarcomatrix Therapeutics Corp. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sarcomatrix Therapeutics Corp.'s valuation, stock price, and market status.